Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C. (2021)

First Author: Cooke GS
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16594.2

PubMed Identifier: 34405118

Publication URI: http://europepmc.org/abstract/MED/34405118

Type: Journal Article/Review

Volume: 6

Parent Publication: Wellcome open research

ISSN: 2398-502X